Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Eddings currently holds 675,139 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Eddings has been a net neutral trader of TGX stock. They have purchased $0 and sold $0 worth of shares.
James Eddings's most recent insider trade was on Sep 5, 2007, when they sold 12,802 shares at $3.90 per share.
James Eddings serves as Executive at THERAGENICS CORP (TGX). They have executed 4 insider transactions totaling $0 over their tenure at the company.
James Eddings holds the position of Executive at THERAGENICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James Eddings has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James Eddings was on Aug 2, 2006, when they purchased $2.0M worth of TGX shares. This transaction involved 610,738 shares at $3.26 per share.
James Eddings currently owns 675,139 shares of THERAGENICS CORP (TGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Eddings's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Eddings has 4 Form 4 filings on record as an insider at THERAGENICS CORP.
Set alerts for James Eddings and 40,000+ other insiders.